Apotex v. USA (II) Apotex Inc. v. The Government of the United States of America (II)
United States of America
Canadian pharmaceuticals corporation engaged in developing and manufacturing generic drugs.
Claims arising out of alleged errors committed by U.S. agencies and federal courts in interpreting federal law, in the course of the investor's efforts to bring new generic drugs to market in the United States.
Secondary: C - Manufacturing
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
ICSID (International Centre for Settlement of Investment Disputes)
Landau, T.
Davidson, C. F.
Smith, F. M.
Decided in favour of State
8.00 mln USD
Data not available
Indirect expropriation

Fair and equitable treatment/Minimum standard of treatment, including denial of justice claims

National treatment
None - jurisdiction declined